EUVIMEDEUVIMED entdecken
Crossref

Quantification of Glycosaminoglycans in Urine by Isotope‐Dilution Liquid Chromatography‐Electrospray Ionization Tandem Mass Spectrometry

Haoyue Zhang, Sarah P Young, David S Millington

Current Protocols · 2023

DOI: 10.1002/cpz1.701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Protocols, 2023. Verfasst von Haoyue Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biochemical Genetics Laboratory, Duke University Health System, Durham, North Carolina. Hauptthemen laut MEDLINE: Mucopolysaccharidoses, Mucopolysaccharidosis I. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucopolysaccharidoses (MPSs) are complex lysosomal storage disorders that result in the accumulation of glycosaminoglycans (GAGs) in urine, blood, and tissues. Lysosomal enzymes responsible for GAG degradation are defective in MPSs. GAGs including chondroitin sulfate (CS), dermatan sulfate (DS), heparan sulfate (HS), and keratan sulfate (KS) are disease‐specific biomarkers for MPSs. This article describes a stable isotope dilution‐tandem mass spectrometric method for quantifying CS, DS, and HS in urine samples. The GAGs are methanolyzed to uronic or iduronic acid‐N‐acetylhexosamine or iduronic acid‐N‐sulfo‐glucosamine dimers and mixed with internal standards derived from deuteriomethanolysis of GAG standards. Specific dimers derived from HS, DS, and CS are separated by ultra‐performance liquid chromatography (UPLC) and analyzed by electrospray ionization tandem mass spectrometry (MS/MS) using selected reaction monitoring for each targeted GAG product and its corresponding internal standard. This UPLC‐MS/MS GAG assay is useful for identifying patients with MPS types I, II, III, VI, and VII. © 2023 Wiley Periodicals LLC. Basic Protocol : Urinary GAG analysis by ESI‐MS/MS Support Protocol 1 : Prepare calibration samples Support Protocol 2 : Preparation of stable isotope‐labeled internal standards Support Protocol 3 : Preparation of quality controls for GAG analysis in urine Support Protocol 4 : Optimization of the methanolysis time Support Protocol 5 : Measurement of the concentration of methanolic HCl

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucopolysaccharidosesMucopolysaccharidosis IHumansGlycosaminoglycansTandem Mass SpectrometryChromatography, LiquidSpectrometry, Mass, Electrospray IonizationIduronic AcidDermatan SulfateHeparan SulfateChondroitin SulfatesIsotopes

Stichwörter der Autor:innen

LC-ESI-MS/MSdermatan sulfateglycosaminoglycansheparan sulfateisotope dilutionmucopolysaccharidosis

Substanzen

GlycosaminoglycansIduronic AcidDermatan SulfateHeparan SulfateChondroitin SulfatesIsotopes

Autor:innen und Institutionen

  • Biochemical Genetics Laboratory, Duke University Health System, Durham, North Carolina.
  • Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.

Zitieren

APA

Zhang, H., Young, S. P., & Millington, D. S. (2023). Quantification of Glycosaminoglycans in Urine by Isotope‐Dilution Liquid Chromatography‐Electrospray Ionization Tandem Mass Spectrometry. Current Protocols. https://doi.org/10.1002/cpz1.701

Vancouver

Zhang H, Young SP, Millington DS. Quantification of Glycosaminoglycans in Urine by Isotope‐Dilution Liquid Chromatography‐Electrospray Ionization Tandem Mass Spectrometry. Current Protocols. 2023. doi:10.1002/cpz1.701

BibTeX
@article{Zhang2023,
  author = {Zhang, Haoyue and Young, Sarah P and Millington, David S},
  title = {Quantification of Glycosaminoglycans in Urine by Isotope‐Dilution Liquid Chromatography‐Electrospray Ionization Tandem Mass Spectrometry},
  journal = {Current Protocols},
  year = {2023},
  doi = {10.1002/cpz1.701}
}
Kostenlos starten →